• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

W.L. Gore & Associates

Judge tosses Gore stent graft suit against Medtronic

June 21, 2012 By MassDevice staff Leave a Comment

MassDevice.com news
MassDevice.com news

A federal judge tossed a lawsuit filed in 2010 accusing Medtronic (NYSE:MDT) of violating patents held by W.L. Gore & Associates covering stent graft manufacturing techniques.

Filed Under: Legal News, News Well, Patent Infringement, Stent Grafts Tagged With: W.L. Gore & Associates

Federal Circuit reverses part of Bard’s $371M patent win over Gore

June 15, 2012 By MassDevice staff Leave a Comment

C.R. Bard logo
W.L. Gore & Associates logo

Filed Under: Legal News, News Well, Patent Infringement, Vascular Tagged With: C.R. Bard, W.L. Gore & Associates

GI Dynamics and Gore creep toward trial in weight-loss device patent dispute

May 31, 2012 By MassDevice staff Leave a Comment

GI Dynamics logo

A long-running dispute between W.L Gore & Associates and GI Dynamics (ASX:GID) stepped closer to trial when an Arizona District Judge affirmed that all but 1 of GI Dynamics’ counterclaims in the patent infringement lawsuit may proceed to trial.

All claims on both sides are ready for trial, and a pretrial conference between the companies is set for July. No trial date has yet been determined.

Filed Under: Legal News, News Well, Patent Infringement, Weight loss Tagged With: GI Dynamics, W.L. Gore & Associates

FDA panel wants a closer look at St. Jude’s Amplatzer data

May 25, 2012 By MassDevice staff Leave a Comment

MassDevice.com news

An FDA panel recommended that the agency’s Center for Devices & Radiological Health re-analyze existing data for St. Jude Medical‘s (NYSE:STJ) Amplatzer heart implant during a hearing yesterday to review safety data for the Amplatzer and for W.L. Gore & Associates‘ Helex implant.

Filed Under: Cardiac Implants, News Well Tagged With: stjudemedical, W.L. Gore & Associates

FDA panel to review St. Jude, W.L. Gore heart implants today

May 24, 2012 By MassDevice staff Leave a Comment

MassDevice.com news

An FDA panel is scheduled for a hearing today to review post-market surveillance data for a pair of cardiac implants made by St. Jude Medical (NYSE:STJ) and W.L. Gore & Associates.

Filed Under: Cardiac Implants, Food & Drug Administration (FDA), News Well Tagged With: NMT Medical Inc., stjudemedical, W.L. Gore & Associates

St. Jude and W.L. Gore heart hole closure systems get a date with the FDA

March 28, 2012 By MassDevice staff Leave a Comment

St. Jude Medical logo

The FDA’s circulatory devices panel will review post-market data for St. Jude Medical‘s (NYSE:STJ) Amplatzer septal occluder* and W.L. Gore’s Helex septal occluder May 24 to discuss concerns about the devices after more than a decade on the U.S. market.

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: stjudemedical, Vascular Closure, W.L. Gore & Associates

IBM’s Watson supercomputer tackles cancer | MassDevice.com On Call

March 22, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — IBM’s Jeopardy-winning Watson supercomputer is taking a swing at oncology research in efforts to help hospitals more quickly diagnose and treat cancer.

Watson can cull through 200 million pages of information in less than 3 seconds, according to IBM, and the machine is getting an education in oncology at Manhattan’s Memorial Sloan-Kettering Cancer Center.

Filed Under: Health Information Technology, News Well, Oncology, Pharmaceutical Tagged With: Abbott, AbbVie, American College of Cardiology, Dept. of Health & Human Services (HHS), Endovascular, IBM, On Call, W.L. Gore & Associates

MassDevice.com +3 | The top 3 med-tech stories for February 10, 2012.

February 11, 2012 By MassDevice staff Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

Filed Under: Food & Drug Administration (FDA), Legal News, News Well, Orthopedics, Pediatrics, Wall Street Beat Tagged With: C.R. Bard, W.L. Gore & Associates

UPDATE: Wall St. reacts to Bard’s $371M win against Gore | Legal News

February 10, 2012 By MassDevice staff Leave a Comment

Updated Feb. 10, 2012, at 1:30 p.m. with share values and analysts’ reactions.

C.R. Bard logo
W.L. Gore & Associates logo

A U.S. federal judge this week upheld C.R. Bard’s (NYSE:BCR) win against W.L. Gore & Associates over vascular graft patents.

Filed Under: Legal News, News Well, Patent Infringement, Stent Grafts, Vascular, Wall Street Beat Tagged With: C.R. Bard, Leerink Partners, W.L. Gore & Associates

Court reaffirms C.R. Bard’s $371M patent win against W.L. Gore | Legal News

February 10, 2012 By MassDevice staff Leave a Comment

C.R. Bard logo
W.L. Gore & Associates logo

A U.S. federal judge this week upheld C.R. Bard’s (NYSE:BCR) win against W.L. Gore & Associates over vascular graft patents.

The court affirmed Bard’s $371 million win from a 2007 decision when an Arizona jury found that Gore willfully infringed on patents for vascular tubing.

Filed Under: Legal News, Patent Infringement, Stent Grafts, Vascular Tagged With: C.R. Bard, W.L. Gore & Associates

FDA approves first endovascular grafts for aortic tears | Regulatory Roundup

January 19, 2012 By MassDevice staff Leave a Comment

Conformable

The FDA granted W.L. Gore & Associates the first U.S. clearance for using an endovascular graft to treat tears or ruptures in the aortic wall.

Gore’s Conformable TAG thoracic endoprosthesis was approved as a treatment for a transection or tear in the aortic wall, an injury typically the result of a car accident, crushing of the chest or a fall from a high place, according to an FDA release.

Filed Under: 510(k), News Well, Stent Grafts Tagged With: Aerocrine AB, CardioComm, Covidien, D Medical Industries, Ivera Medical, Planmed, Torax Medical Inc., W.L. Gore & Associates

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 7
  • Go to page 8
  • Go to page 9
  • Go to page 10
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS